Swiss National Bank
ALXN

Swiss National Bank’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-900,881
Closed -$166M 2636
2021
Q2
$166M Buy
900,881
+58,950
+7% +$10.8M 0.1% 190
2021
Q1
$129M Buy
841,931
+14,300
+2% +$2.19M 0.09% 236
2020
Q4
$129M Sell
827,631
-31,900
-4% -$4.98M 0.09% 219
2020
Q3
$98.4M Sell
859,531
-15,900
-2% -$1.82M 0.08% 251
2020
Q2
$98.3M Buy
875,431
+16,600
+2% +$1.86M 0.08% 236
2020
Q1
$77.1M Buy
858,831
+151,800
+21% +$13.6M 0.08% 237
2019
Q4
$76.5M Sell
707,031
-33,500
-5% -$3.62M 0.08% 264
2019
Q3
$72.5M Buy
740,531
+11,890
+2% +$1.16M 0.08% 270
2019
Q2
$95.4M Sell
728,641
-16,000
-2% -$2.1M 0.1% 206
2019
Q1
$101M Buy
744,641
+20,200
+3% +$2.73M 0.11% 194
2018
Q4
$70.5M Buy
724,441
+14,100
+2% +$1.37M 0.09% 229
2018
Q3
$98.7M Sell
710,341
-22,900
-3% -$3.18M 0.11% 194
2018
Q2
$91M Buy
733,241
+16,400
+2% +$2.04M 0.1% 206
2018
Q1
$79.9M Sell
716,841
-106,000
-13% -$11.8M 0.1% 221
2017
Q4
$98.4M Sell
822,841
-4,300
-0.5% -$514K 0.11% 197
2017
Q3
$116M Buy
827,141
+6,400
+0.8% +$898K 0.13% 171
2017
Q2
$99.9M Buy
820,741
+26,100
+3% +$3.18M 0.12% 190
2017
Q1
$96.3M Buy
794,641
+170,100
+27% +$20.6M 0.12% 189
2016
Q4
$76.4M Buy
624,541
+2,800
+0.5% +$343K 0.12% 191
2016
Q3
$76.2M Sell
621,741
-9,600
-2% -$1.18M 0.12% 187
2016
Q2
$73.7M Buy
631,341
+46,000
+8% +$5.37M 0.12% 192
2016
Q1
$78.1M Buy
585,341
+174,400
+42% +$23.3M 0.14% 156
2015
Q4
$78.4M Buy
410,941
+10,900
+3% +$2.08M 0.19% 119
2015
Q3
$62.6M Buy
400,041
+38,500
+11% +$6.02M 0.16% 145
2015
Q2
$65.4M Buy
361,541
+59,524
+20% +$10.8M 0.17% 140
2015
Q1
$52.3M Buy
302,017
+118,600
+65% +$20.6M 0.14% 171
2014
Q4
$33.9M Sell
183,417
-6,200
-3% -$1.15M 0.13% 177
2014
Q3
$31.4M Sell
189,617
-3,200
-2% -$531K 0.12% 192
2014
Q2
$30.1M Buy
192,817
+2,800
+1% +$438K 0.11% 208
2014
Q1
$28.9M Sell
190,017
-18,400
-9% -$2.8M 0.11% 203
2013
Q4
$27.7M Sell
208,417
-2,900
-1% -$386K 0.11% 213
2013
Q3
$24.5M Buy
211,317
+3,600
+2% +$418K 0.1% 226
2013
Q2
$19.2M Buy
+207,717
New +$19.2M 0.08% 256